EU Malaria Fund adds VicuTec to its portfolio
keller • 18. Dezember 2020
Every two minutes, a child below the age of five dies from Malaria.
During its 8th Session held on December 18, 2020, the Scientific Advisory Council of the EU Malaria Fund has included VicuTec Biologicals GmbH to the Fund's portfolio. The EU Malaria Fund is a public-private partnership between the European Union, International Organizations, corporations, and organized civic society, providing a novel funding instrument to address market failures in infectious diseases with significant relevance to public health globally. For more information, please click here.
Dr. Sabine Johannsen (third from right), with the Scientific Founders of VicuTec at the Max Planck Institute for Biophysical Chemistry in Göttingen / Germany.
